- Home
- VSTA vs SGMO Comparison
VSTA vs SGMO Comparison
Compare VSTA & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VSTA
- SGMO
- Stock Information
- Founded
- VSTA 1966
- SGMO 1995
- Country
- VSTA Brazil
- SGMO United States
- Employees
- VSTA N/A
- SGMO N/A
- Industry
- VSTA Other Consumer Services
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- VSTA Real Estate
- SGMO Health Care
- Exchange
- VSTA Nasdaq
- SGMO Nasdaq
- Market Cap
- VSTA 204.2M
- SGMO 180.5M
- IPO Year
- VSTA 2020
- SGMO 2000
- Fundamental
- Price
- VSTA $2.52
- SGMO $1.96
- Analyst Decision
- VSTA Sell
- SGMO Buy
- Analyst Count
- VSTA 2
- SGMO 3
- Target Price
- VSTA $3.00
- SGMO $7.00
- AVG Volume (30 Days)
- VSTA 12.0K
- SGMO 11.1M
- Earning Date
- VSTA 11-07-2024
- SGMO 11-12-2024
- Dividend Yield
- VSTA N/A
- SGMO N/A
- EPS Growth
- VSTA N/A
- SGMO N/A
- EPS
- VSTA N/A
- SGMO N/A
- Revenue
- VSTA $280,865,717.00
- SGMO $52,291,000.00
- Revenue This Year
- VSTA $13.10
- SGMO N/A
- Revenue Next Year
- VSTA $11.42
- SGMO $71.79
- P/E Ratio
- VSTA N/A
- SGMO N/A
- Revenue Growth
- VSTA 6.41
- SGMO N/A
- 52 Week Low
- VSTA $2.11
- SGMO $0.30
- 52 Week High
- VSTA $4.55
- SGMO $3.18
- Technical
- Relative Strength Index (RSI)
- VSTA 45.90
- SGMO 51.89
- Support Level
- VSTA $2.48
- SGMO $1.82
- Resistance Level
- VSTA $2.64
- SGMO $2.11
- Average True Range (ATR)
- VSTA 0.15
- SGMO 0.38
- MACD
- VSTA -0.01
- SGMO -0.10
- Stochastic Oscillator
- VSTA 35.34
- SGMO 16.44
About VSTA Vasta Platform Limited
Vasta Platform Ltd operates as an education company in Brazil, engaged in providing end-to-end educational and digital solutions that cater to all needs of private schools operating in the K-12 educational segment. Its business segments are Content and EdTech Platform, and Digital Platform. The Content and EdTech platform derives its results from educational content solutions through digital and printed content, including textbooks, learning systems and other complementary educational services. The Digital Platform enables private schools to aggregate multiple learning strategies and helps them to focus on education through the Business' physical and digital e-commerce platform and other digital services.
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.